| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |